Skip to main content
Clinical Trials/JPRN-jRCTs042220128
JPRN-jRCTs042220128RecruitingPhase 3

A study on the effectiveness of gait training using WelWalk on improving gait independence in patients with paraplegia. - EGTWIP

Yohei Otaka0 sites300 target enrollmentStarted: January 27, 2023Last updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 16age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • 1. Individuals who have obtained written consent to participate in this study from the individual or his/her surrogate
  • 2. Individuals who are more than 16 years old
  • 3. Individuals with brain, cerebrovascular, or spinal cord disease
  • 4. Individuals whose weigh range from 35 kg to 100 kg
  • 5. Individuals whose height range from 140 cm to 190 cm

Exclusion Criteria

  • 1. Individuals with uncontrolled hypertension/hypotension
  • 2. Individuals with uncontrolled cardiac or respiratory dysfunction
  • 3. Individuals with a pacemaker device
  • 4. Individuals with lower extremity hemodynamic disturbances that contraindicate exercise therapy
  • 5. Individuals with fracture susceptibility of the lower limbs or spine (e.g., severe osteoporosis)
  • 6. Individuals with heterotopic ossification of the lower extremity leading to joint range of motion limitation
  • 7. Individuals who are pregnant or may be pregnant
  • 8. Individuals with infectious diseases requiring isolation
  • 9. Individuals who are unable to wear the robotic leg due to oversized or deformed lower limbs or pressure ulcers
  • 10. Other individuals who judged inappropriate by the attending physician, investigator, or research assistants

Investigators

Sponsor
Yohei Otaka

Similar Trials